Granite Protocol Listing Shows Bitcoin DeFi Is Still Building On Stacks
Granite Protocol has been listed on Borrow on Bitcoin, adding another lending route for users who want to put Bitcoin-linked collateral to work without leaving the broader Bitcoin DeFi stack.
The listing centers on Granite’s Stacks-based lending market, where users can deposit sBTC collateral and borrow USDCx. The validated notes point to a variable borrow rate of 1.66% APR, along with features including isolated pools, soft liquidations, and no rehypothecation of user collateral.
The product is not available in the US, and that limitation matters.
Still, the listing is another sign that Bitcoin DeFi is becoming more specific. Instead of broad claims that Bitcoin can support DeFi one day, the market is now seeing comparison pages, lending markets, collateral routes, and user-facing products built around BTC-linked assets.
That does not mean Bitcoin DeFi has gone mainstream. It means the infrastructure is becoming easier to evaluate.
TL;DR
- Granite Protocol has been listed on Borrow on Bitcoin.
- Users can deposit sBTC collateral on Stacks to borrow USDCx.
- The integration is a useful Bitcoin DeFi signal, but it should not be overstated as broad adoption.
Bitcoin DeFi Needs Practical Products
Bitcoin DeFi has always had a slightly awkward pitch.
Bitcoin is the largest crypto asset and the strongest store-of-value brand in the market, but most DeFi activity historically happened elsewhere. Ethereum, Solana, BNB Chain, and newer Layer 2 ecosystems built the lending markets, DEXs, stablecoin systems, yield protocols, and composable financial apps.
Bitcoin had the capital. Other chains had the app layer.
Stacks has been one of the ecosystems trying to close that gap by giving Bitcoin holders more ways to interact with DeFi-style products while keeping the narrative tied to BTC.
Granite’s Borrow on Bitcoin listing fits that direction.
It gives users another way to compare borrowing options, collateral terms, and risk models in a Bitcoin-linked environment.
The 1.66% APR Detail Gets Attention
A 1.66% variable borrow rate is the kind of number that immediately attracts attention, especially if traders compare it with higher borrowing costs in other markets.
But the rate should be treated carefully.
Borrow rates can change. They depend on utilization, available liquidity, risk parameters, market demand, and protocol design. A low advertised rate is useful, but it is not a guarantee that conditions will remain the same.
The more important point is that Bitcoin DeFi products are starting to compete on familiar lending-market terms.
Users can ask practical questions: What collateral do I deposit? What stablecoin can I borrow? What happens in liquidation? Is the pool isolated? Is collateral rehypothecated? What jurisdictions are supported? Where is the liquidity coming from?
Those are normal DeFi questions, and that is progress.
Bitcoin DeFi becomes real when users can compare products by actual risk and cost, not just by slogans.
Why Soft Liquidations Matter
The soft liquidation feature is important because liquidation design shapes user experience.
In traditional DeFi lending, a sharp move against collateral can trigger liquidation. If the system is aggressive, users may lose more than expected or have little time to react. Softer liquidation mechanics are designed to reduce the shock, though the exact effect depends on protocol design.
For Bitcoin-backed borrowing, liquidation risk is one of the main barriers.
Bitcoin holders often do not want to sell BTC, but they may want liquidity. Borrowing against BTC-linked collateral offers that route, but a sudden BTC drawdown can put the position at risk.
A product that emphasizes soft liquidations is trying to make that borrowing experience less brutal.
That does not eliminate risk. It just changes how the protocol handles stress.
No Rehypothecation Is A Custody Signal
Granite’s no-rehypothecation claim is also worth noting.
Rehypothecation became a dirty word after the last cycle’s lending failures, where users learned that “earn” and “borrow” products often involved hidden layers of counterparty risk. If collateral is reused, lent onward, or tied into opaque strategies, users may be exposed to risks they did not understand.
A protocol that does not rehypothecate collateral is making a clearer custody and risk claim.
That does not make the system risk-free. Smart contract risk, oracle risk, liquidity risk, liquidation risk, bridge risk, and governance risk can still exist. But it does address one of the biggest trust problems from centralized lending.
Bitcoin users are usually especially sensitive to custody assumptions, so that design detail matters.
A Small But Useful Bitcoin DeFi Step
The right way to read this listing is measured.
Granite landing on Borrow on Bitcoin does not prove that Bitcoin DeFi has reached escape velocity. It does not mean BTC holders are suddenly moving in size to Stacks lending markets. It does not make Bitcoin an Ethereum-style DeFi ecosystem overnight.
But it does show continued product formation.
Comparison indexes, collateralized lending markets, stablecoin borrowing routes, and clearer risk terms are the kind of boring infrastructure that needs to exist before larger adoption becomes possible.
Bitcoin DeFi will not grow through one headline. It will grow if users find products that are cheaper, safer, clearer, and more useful than the alternatives.
Granite’s listing is one more test of whether that market is starting to form.
This article is based on Granite Protocol and Borrow on Bitcoin product materials.
This article was written by the News Desk and edited by Samuel Rae.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Phase III trial failure for new heart drug causes Novo Nordisk shares to plunge: increasing reliance on weight-loss drugs, R&D transformation faces new test
Novo Nordisk announced on Friday that its cardiovascular drug ziltivekimab failed to reduce the risk of major cardiovascular events in a phase III clinical trial involving 6,300 patients, causing its stock price to plummet by 8.7% in a single day. The market had held high expectations for ziltivekimab, hoping the drug would establish a second growth curve beyond diabetes and weight-loss medications.
Ondo Perps trading volume surpasses $300 million, ONDO targets $0.47 breakout
Financial Gravity Is Broken: 5 Altcoins Worth Holding as Altseason 2026 Enters Full Hyperdrive

Hyperliquid holds key $53 support as daily trading volume reaches $13.5 billion
